| dc.contributor.author | Cornea, Cornelia | |
| dc.contributor.author | Rotaru, Larisa | |
| dc.contributor.author | Groppa, Liliana | |
| dc.contributor.author | Russu, Eugeniu | |
| dc.contributor.author | Sasu, Dorian | |
| dc.contributor.author | Cazac, Victor | |
| dc.date.accessioned | 2020-11-13T16:16:20Z | |
| dc.date.available | 2020-11-13T16:16:20Z | |
| dc.date.issued | 2020-10 | |
| dc.identifier.uri | https://stiinta.usmf.md/ro/manifestari-stiintifice/zilele-universitatii | |
| dc.identifier.uri | https://repository.usmf.md/handle/20.500.12710/12980 | |
| dc.description | Discipline of Rheumathology and Nephrology, Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova, Ziua internațională a științei pentru pace și dezvoltare | en_US |
| dc.description.abstract | Introduction.The association between gout and kidney diseases has long been recognized. Kidney disease is very common in patients who have suffered from gouty arthritis for many years. Renal involvement is the most common manifestation of hyperuricemia after arthritis.Purpose.To study the clinical features and evolution of renal impairment in patients with gout.Conclusions.1. Renal impairment occurs in the early stages of gout, in 25.0 ± 2.9% of patients. 2. The prophylaxis of kidney disease is paramount in gout, because renal dysfunction leads to decreased excretion of uric acid, hence uric acid rises in the serum, and causes more pronounced disorders. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Universitatea de Stat de Medicină şi Farmacie "Nicolae Testemiţanu" | en_US |
| dc.subject | gout | en_US |
| dc.subject | kidney damage nephrolithiasis | en_US |
| dc.title | Kidney disease in gout | en_US |
| dc.type | Other | en_US |